Primary prophylactic aspirin use and incident stroke: Reasons for geographic and racial differences in stroke study

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 4, 2013, Pages 500-507

  Glasser, Stephen P ^a,b   Hovater, Martha K ^b   Lackland, Daniel T ^c   Cushman, Mary ^d   Howard, George ^b   Howard, Virginia J ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Aspirin; primary prevention; racial differences; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOVASCULAR AGENT;

ADULT; AFRICAN AMERICAN; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDUCATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEALTH STATUS; HUMAN; HYPERTENSION; INCOME; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEGRO; POPULATION RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; CHI SQUARE DISTRIBUTION; COMORBIDITY; DEMOGRAPHY; EPIDEMIOLOGY; ETHNOLOGY; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; UNITED STATES; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RESIDENCE CHARACTERISTICS; RISK FACTORS; STROKE; UNITED STATES;

EID: 84877056314     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.004     Document Type: Article

References (20)

1. P.M. Ridker, M. Cushman, and M.J. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
2. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
3. US Preventive Services Task Force Aspirin for the primary prevention of cardiovascular events: recommendation and rationale Ann Intern Med 136 2002 157 160
4. Steering Committee of the Physicians' Health Study Research Group Final Report on the Aspirin Component of the Ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
5. L.B. Goldstein, R. Adams, and M.J. Alberts Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline Stroke 37 2006 1583 1633
6. J.R. Pleis, B.W. Ward, and J.W. Lucas Summary health statistics for U.S. adults: National Health Interview Survey, 2009 Vital and health statistics Series 10, Data from the National Health Survey 2010 1 207
7. M.L. Casper, S. Wing, and R.F. Anda The shifting stroke belt. Changes in the geographic pattern of stroke mortality in the United States, 1962 to 1988 Stroke 26 1995 755 760
8. V.J. Howard, M. Cushman, and L. Pulley The Reasons for Geographic and Racial Differences in Stroke Study: objectives and design Neuroepidemiology 25 2005 135 143
9. Centers for Disease Control and Prevention (CDC) Regional and racial differences in prevalence of stroke-23 states and District of Columbia, 2003 MMWR 54 2003 481 484
10. H.J. Fullerton, J.S. Elkins, and S.C. Johnston Pediatric Stroke Belt: Geographic variation in stroke mortality in US children Stroke 35 2004 1570 1573
11. S. Glasser, M. Cushman, and R.J. Prineas Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke? Prev Med 47 2008 161 166
12. S. Galea, and M. Tracy Participation rates in epidemiologic studies Ann Epidemiol 17 2007 643 653
13. G. Howard, L.A. McClure, and C.S. Moy Imputation of incident events in longitudinal cohort studies Am J Epidemiol 174 2011 718 726
14. D.E. Morisky, L.W. Green, and D.M. Levine Concurrent and predictive validity of a self-reported measure of medication adherence Med Care 24 1986 67 74
15. L.B. Goldstein, C.D. Bushnell, and R.J. Adams Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 517 584
16. T.A. Pearson, S.N. Blair, and S.R. Daniels AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee Circulation 106 2002 388 391
17. G.H. Guyatt, E.A. Akl, and M. Crowther Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 11 2 Suppl 2012 7S 47S
18. H. Ogawa, M. Nakayama, and T. Morimoto Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JAMA 300 2008 2134 2141
19. J. Belch, A. MacCuish, and I. Campbell The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease BMJ 337 2008 a1840
20. S.R. Seshasai, S. Wijesuriya, and R. Sivakumaran Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials Arch Intern Med 172 2012 209 216